Copernicus Capital Management, LLC Buys CVS Health Corp, Hologic Inc, Integra Lifesciences Holdings Corp, Sells Cigna Corp, Biogen Inc, Gilead Sciences Inc

Investment company Copernicus Capital Management, LLC buys CVS Health Corp, Hologic Inc, Integra Lifesciences Holdings Corp, Edwards Lifesciences Corp, Henry Schein Inc, Clovis Oncology Inc, Stryker Corp, DaVita Inc, Humana Inc, Array BioPharma Inc, sells Cigna Corp, Biogen Inc, Gilead Sciences Inc, Alexion Pharmaceuticals Inc, Molina Healthcare Inc during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, Copernicus Capital Management, LLC. As of 2018-06-30, Copernicus Capital Management, LLC owns 19 stocks with a total value of $138 million. These are the details of the buys and sells.

For the details of Copernicus Capital Management, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Copernicus+Capital+Management%2C+LLC

These are the top 5 holdings of Copernicus Capital Management, LLC
  1. Stryker Corp (SYK) - 70,209 shares, 8.6% of the total portfolio. Shares added by 34.99%
  2. Thermo Fisher Scientific Inc (TMO) - 55,645 shares, 8.37% of the total portfolio. Shares added by 26.47%
  3. Intuitive Surgical Inc (ISRG) - 24,073 shares, 8.36% of the total portfolio. Shares added by 2.06%
  4. Illumina Inc (ILMN) - 41,124 shares, 8.34% of the total portfolio. Shares added by 4.17%
  5. Vertex Pharmaceuticals Inc (VRTX) - 66,440 shares, 8.2% of the total portfolio. Shares added by 27.17%
New Purchase: CVS Health Corp (CVS)

Copernicus Capital Management, LLC initiated holding in CVS Health Corp. The purchase prices were between $60.71 and $72.18, with an estimated average price of $65.94. The stock is now traded at around $71.51. The impact to a portfolio due to this purchase was 6.33%. The holding were 135,595 shares as of 2018-06-30.

New Purchase: Hologic Inc (HOLX)

Copernicus Capital Management, LLC initiated holding in Hologic Inc. The purchase prices were between $36.43 and $40.46, with an estimated average price of $38.47. The stock is now traded at around $38.23. The impact to a portfolio due to this purchase was 4.89%. The holding were 169,511 shares as of 2018-06-30.

New Purchase: Integra Lifesciences Holdings Corp (IART)

Copernicus Capital Management, LLC initiated holding in Integra Lifesciences Holdings Corp. The purchase prices were between $54.05 and $67.23, with an estimated average price of $61.88. The stock is now traded at around $61.92. The impact to a portfolio due to this purchase was 2.95%. The holding were 63,000 shares as of 2018-06-30.

New Purchase: Henry Schein Inc (HSIC)

Copernicus Capital Management, LLC initiated holding in Henry Schein Inc. The purchase prices were between $65.83 and $76.87, with an estimated average price of $71.9. The stock is now traded at around $78.25. The impact to a portfolio due to this purchase was 2.9%. The holding were 55,000 shares as of 2018-06-30.

New Purchase: Humana Inc (HUM)

Copernicus Capital Management, LLC initiated holding in Humana Inc. The purchase prices were between $273.25 and $306.95, with an estimated average price of $292.86. The stock is now traded at around $325.76. The impact to a portfolio due to this purchase was 2.16%. The holding were 10,000 shares as of 2018-06-30.

Added: Edwards Lifesciences Corp (EW)

Copernicus Capital Management, LLC added to a holding in Edwards Lifesciences Corp by 92.32%. The purchase prices were between $127.36 and $153.9, with an estimated average price of $140.07. The stock is now traded at around $137.31. The impact to a portfolio due to this purchase was 2.94%. The holding were 58,000 shares as of 2018-06-30.

Added: Clovis Oncology Inc (CLVS)

Copernicus Capital Management, LLC added to a holding in Clovis Oncology Inc by 98.82%. The purchase prices were between $42.06 and $62.4, with an estimated average price of $48.66. The stock is now traded at around $35.12. The impact to a portfolio due to this purchase was 2.32%. The holding were 141,345 shares as of 2018-06-30.

Added: Stryker Corp (SYK)

Copernicus Capital Management, LLC added to a holding in Stryker Corp by 34.99%. The purchase prices were between $155.17 and $179.78, with an estimated average price of $168.09. The stock is now traded at around $166.23. The impact to a portfolio due to this purchase was 2.23%. The holding were 70,209 shares as of 2018-06-30.

Added: DaVita Inc (DVA)

Copernicus Capital Management, LLC added to a holding in DaVita Inc by 46.08%. The purchase prices were between $62.77 and $73.47, with an estimated average price of $66.81. The stock is now traded at around $71.72. The impact to a portfolio due to this purchase was 2.19%. The holding were 137,496 shares as of 2018-06-30.

Added: Array BioPharma Inc (ARRY)

Copernicus Capital Management, LLC added to a holding in Array BioPharma Inc by 118.23%. The purchase prices were between $13.49 and $19.99, with an estimated average price of $15.91. The stock is now traded at around $13.77. The impact to a portfolio due to this purchase was 1.89%. The holding were 286,797 shares as of 2018-06-30.

Added: Thermo Fisher Scientific Inc (TMO)

Copernicus Capital Management, LLC added to a holding in Thermo Fisher Scientific Inc by 26.47%. The purchase prices were between $203.14 and $219.53, with an estimated average price of $212.33. The stock is now traded at around $228.25. The impact to a portfolio due to this purchase was 1.75%. The holding were 55,645 shares as of 2018-06-30.

Sold Out: Cigna Corp (CI)

Copernicus Capital Management, LLC sold out a holding in Cigna Corp. The sale prices were between $164.65 and $180.95, with an estimated average price of $173.16.

Sold Out: Biogen Inc (BIIB)

Copernicus Capital Management, LLC sold out a holding in Biogen Inc. The sale prices were between $257.52 and $306.91, with an estimated average price of $280.94.

Sold Out: Gilead Sciences Inc (GILD)

Copernicus Capital Management, LLC sold out a holding in Gilead Sciences Inc. The sale prices were between $64.88 and $75.68, with an estimated average price of $70.67.

Sold Out: Alexion Pharmaceuticals Inc (ALXN)

Copernicus Capital Management, LLC sold out a holding in Alexion Pharmaceuticals Inc. The sale prices were between $106.04 and $127.57, with an estimated average price of $116.88.

Sold Out: Service Corp International (SCI)

Copernicus Capital Management, LLC sold out a holding in Service Corp International. The sale prices were between $35.3 and $38.88, with an estimated average price of $37.06.

Sold Out: Celgene Corp (CELG)

Copernicus Capital Management, LLC sold out a holding in Celgene Corp. The sale prices were between $74.69 and $92.08, with an estimated average price of $83.1.



Here is the complete portfolio of Copernicus Capital Management, LLC. Also check out:

1. Copernicus Capital Management, LLC's Undervalued Stocks
2. Copernicus Capital Management, LLC's Top Growth Companies, and
3. Copernicus Capital Management, LLC's High Yield stocks
4. Stocks that Copernicus Capital Management, LLC keeps buying